$HAO

Haoxi Health Technology Ltd

No enriched coverage for $HAO in the last 7 days.

No SEC Form 4 filings for $HAO in the last 30 days.

See all $HAO insider activity →

Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System

Haoxi Health Technology Limited (HAO) said it signed a strategic cooperation framework with NOVA MEDIA to develop an AI digital marketing system for HAO. The system will use AI digital humans, automated content generation, and workflow automation to support health-industry marketing across platforms including Toutiao, Douyin, WeChat, and Sina Weibo.

HAO sentiment & insider activity

Recent HAO coverage spans financial news, corporate actions and earnings.

What's driving HAO

AlphAI scores every news story that mentions HAO with an AI model for sentiment and relevance, and aggregates insider trades from Haoxi Health Technology Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HAO

Score

Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System

Haoxi Health Technology Limited (HAO) said it signed a strategic cooperation framework with NOVA MEDIA to develop an AI digital marketing system for HAO. The system will use AI digital humans, automated content generation, and workflow automation to support health-industry marketing across platforms including Toutiao, Douyin, WeChat, and Sina Weibo.

$HAOLow

Liu Jia at Haoxi Health (NASDAQ: HAO) files initial Form 3 report

Haoxi Health Technology Ltd director Liu Jia has submitted an initial insider ownership report on Form 3. The filing indicates Liu Jia is a director of the company but shows no reported transactions, share purchases, sales, or derivative positions for the reporting person. The document also provides details on the SEC Form 3 and clarifies that no securities are beneficially owned according to this initial report.

$HAOMed

Haoxi Health Technology launches $80 million at-the-market share offering

Haoxi Health Technology Ltd (NASDAQ:HAO) announced an $80 million at-the-market (ATM) equity offering program through a sales agreement with Aegis Capital Corp. Aegis Capital will act as the sales agent, receiving a 2.5% commission on gross proceeds, with shares to be sold on the Nasdaq Stock Market. This offering is based on an SEC-effective shelf registration statement from June 2025.

Related tickers